Medicare AdvantageCoverageMedium impact
Functional Electrical Stimulators (Non-Pain) - Medicare Advantage (Revised)
Humana·Physical Therapy, PM&R (Physical Medicine & Rehab), Neurology +1 more·Medicare Advantage
We identified it
Aug 4, 2026
Summary
This Medicare Advantage policy clarifies coverage for Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulation (FES) devices used to improve muscle function in patients with conditions like spinal cord injury. Unlike TENS/ICS devices (pain management), NMES are intended for therapeutic muscle activation and atrophy mitigation. The policy distinguishes these devices from pain management stimulators and establishes coverage parameters for this device category.
Action Required
Immediately: Billing and clinical teams must review this policy to distinguish between NMES/FES devices (muscle function improvement) versus TENS/ICS devices (pain management) in claim submissions. Identify any current claims being billed for NMES/FES devices and verify they align with this policy's coverage criteria. Training should clarify that NMES devices require documentation of therapeutic intent (muscle activation, atrophy prevention) rather than pain relief. Contact Humana for specific billing codes and prior authorization requirements, as this summary does not include complete coding guidance. Verify with providers that clinical documentation supports the therapeutic indication for NMES/FES before claim submission to avoid denials.